To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
|Articles|August 5, 2022
News Roundup: August 1 to August 5
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Become the Pharmacy of the Future With Technology Solutions
Technology can help manage every aspect of the pharmacy.
Flu Vaccination and Older Hospitalized Adults with Cardiovascular Disease: What are the Benefits?
A study published in the International Journal of Infectious Diseases found flu vaccines reduced in-hospital deaths and recurrent hospitalizations for older hospitalized adults with cardiovascular disease.
FDA Approves Ustekinumab for Treating Psoriatic Arthritis in Children
Janssen Pharmaceutical Companies of Johnson & Johnson announced the approval of ustekinumab as a new treatment option for patients aged 6 years or older with active psoriatic arthritis.
Care Fragmentation Thwarts Progress in Diabetes Reduction
More financial incentives for high-value services, greater data interoperability are needed to address problem
Examining Connections Between Migraine and Mental Health
Survey results addressed connections between migraine and mental health, stigma, and treatment preferences.
Advertisement
Related to this article
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
A newly erected Women’s Health Division within NIH will work in tandem with the Office of Research on Women’s Health.
Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.
Harini Bupathi, Esq, explains why pharmacies need to continue prioritizing PBM relationships despite rapid legislative change.
Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.
AJ Barbarito, Esq, explains how ERISA and Medicare Part D preemption limit state PBM laws and why a private right of action may be the most effective path forward.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
2
American Pharmacists Month: The Importance of Pharmacy-PBM Relationships
3
Q&A: Why Enforcement Is the Weak Link in State PBM Reform | NCPA 2026
4
White House Declares Increased Focus on Women’s Health in US
5